GSK Plc’s blood cancer drug failed to secure the backing of a panel of US regulatory advisers, putting its approval in doubt.

The comeback story of belantamab mafodotin (Blenrep) hit a roadblock Thursday as the FDA's Oncologic Drugs Advisory Committee ...

Tesla (NASDAQ:TSLA) has selected Liberty General Insurance and Acko as its preferred insurance partners for its entry into the Indian market, according to the Press Trust of India.